Delia Resiga-Susan
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Blockade of colon cancer metastasis via single and double silencing of PCSK7/PCSK9: enhanced T cells cytotoxicity in mouse and human.
Journal: Journal for immunotherapy of cancer
Published: May 15, 2025
PCSK7: A novel regulator of apolipoprotein B and a potential target against non-alcoholic fatty liver disease.
Journal: Metabolism: clinical and experimental
Published: April 21, 2023
SKI-1/S1P Facilitates SARS-CoV-2 Spike Induced Cell-to-Cell Fusion via Activation of SREBP-2 and Metalloproteases, Whereas PCSK9 Enhances the Degradation of ACE2.
Journal: Viruses
Published: December 15, 2022
Erratum for Essalmani et al., "Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity".
Journal: Journal of virology
Published: June 06, 2022
Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
Journal: Journal of virology
Published: March 28, 2022
Asialoglycoprotein receptor 1 is a novel PCSK9-independent ligand of liver LDLR cleaved by furin.
Journal: The Journal of biological chemistry
Published: April 08, 2021
In Vivo Analysis of the Contribution of Proprotein Convertases to the Processing of FGF23.
Journal: Frontiers in endocrinology
Published: April 03, 2021
Ser-Phosphorylation of PCSK9 (Proprotein Convertase Subtilisin-Kexin 9) by Fam20C (Family With Sequence Similarity 20, Member C) Kinase Enhances Its Ability to Degrade the LDLR (Low-Density Lipoprotein Receptor).
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: September 26, 2019
Proprotein convertase 7 (PCSK7) reduces apoA-V levels.
Journal: The FEBS journal
Published: August 07, 2019
Functional analysis of natural PCSK9 mutants in modern and archaic humans.
Journal: The FEBS journal
Published: March 20, 2019
Last Updated: 09/26/2026